Ana Boban and Flora Peyvandi
Feb 17, 2026, 14:32
Flora Peyvandi: Population Pharmacokinetics to Guide Tailored Surgical Dosing in Von Willebrand Disease
Flora Peyvandi, Professor of Internal Medicine – Hemostasis and Thrombosis Unit at University of Milan, shared a post on X about a recent article by Ana Boban published in Blood Advances:
“Population PK of aVWF: toward personalized surgery”
Title: Population PK of VWF: toward personalized surgery
Author: Ana Boban
Read the Full Article on Blood Advances.
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Sep 5, 2026, 15:09Consuela A. Albright: Clinical Advocacy in Sickle Cell Disease
-
Sep 5, 2026, 15:00Brandon Buck: Human Cell-Free DNA as a Diagnostic Tool for Aging and Rare Blood Disorders
-
Sep 5, 2026, 14:57Archil Jaliashvili: What if Normal Hb and SpO₂ Still Do not Mean Adequate Tissue Oxygenation?
-
Sep 5, 2026, 14:52Evaluating Inhibitor Risk Following Factor Product Switches – Results from ATHN 2
-
Sep 5, 2026, 14:50Sandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate
-
Sep 5, 2026, 14:43Nandini Pethe: How Digital Logs Help Recognize Pediatric von Willebrand Disease
-
Sep 5, 2026, 14:36Aremu David: Solving Tic-Tac-Toe in 7ms: How I Built Nine
-
Sep 5, 2026, 13:05Sheharyar Raza: Threshold-Based Transfusion in Sickle Cell Disease
-
Sep 5, 2026, 12:34Stijn Wigerinck: A Practical Roadmap for Eosinophilia and Hypereosinophilia